Prosight Management, LP - 03 Feb 2026 SCHEDULE 13G Report for Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX)

Filing Manager
Prosight Management, LP
Reporting Manager
W. Lawrence Hawkins
Security
Janux Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
JANX
Shares outstanding
59,570,189 shares
Disclosed Ownership
3,157,220 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
06 Feb 2026, 16:23:27 UTC
Date of event
03 Feb 2026
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Prosight Management, LP 5.2% 3,150,970 0 3,150,970 Prosight Partners, LLC General Partner
Prosight Fund, LP 0.2% 148,416 0 148,416 Prosight Management, LP General Partner
Prosight Plus Fund, LP 1.1% 685,220 0 685,220 Prosight Management, LP General Partner
Prosight Partners, LLC 5.2% 3,150,970 0 3,150,970 /s/ W. Lawrence Hawkins Sole Manager
W. Lawrence Hawkins 5.3% 3,157,220 6,250 3,150,970 /s/ W. Lawrence Hawkins W. Lawrence Hawkins